SURMODICS, INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1979-01-01
- Employees
- 376
- Market Cap
- -
- Website
- http://www.surmodics.com
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Pounce™ Thrombectomy System Retrospective Registry
- Conditions
- Peripheral Arterial DiseaseAcute Limb Ischemia
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT05868161
- Locations
- 🇺🇸
OSF St. Francis Medical Center, Peoria, Illinois, United States
🇺🇸Community Hospital, Munster, Indiana, United States
🇺🇸Baton Rouge General Medical Center, Baton Rouge, Louisiana, United States
SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study
- Conditions
- Peripheral Vascular Occlusive Disease
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05600816
Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon
- Conditions
- Critical Lower Limb IschemiaPeripheral Arterial Disease
- First Posted Date
- 2019-09-27
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT04107298
- Locations
- 🇦🇺
Royal Perth Hospital, Perth, Australia
🇦🇺Prince of Wales Private Hospital, Randwick, Australia
🇦🇺Royal North Shore Hospital, St Leonards, Australia
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)
- Conditions
- Hemodialysis Access Failure
- First Posted Date
- 2018-11-08
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03734679
- Locations
- 🇦🇺
Prince of Wales Private Hospital, Randwick, New South Wales, Australia
🇳🇿Auckland City Hospital, Auckland, New Zealand
Safety and Efficacy of the SurVeil™ Drug-Coated Balloon
- Conditions
- Peripheral Vascular DiseaseFemoropopliteal Artery OcclusionArtery Disease, PeripheralPeripheral Arterial Disease
- First Posted Date
- 2017-08-07
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- SurModics, Inc.
- Target Recruit Count
- 446
- Registration Number
- NCT03241459
- Locations
- 🇺🇸
Cardiovascular Associates of the Southeast, Birmingham, Alabama, United States
🇺🇸Cardiology Associates, Foley, Alabama, United States
🇺🇸Dignity Health, Gilbert, Arizona, United States
- Prev
- 1
- 2
- Next